nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprindine—ORM1—Vismodegib—skin cancer	0.428	0.512	CbGbCtD
Aprindine—ORM1—Vemurafenib—skin cancer	0.338	0.404	CbGbCtD
Aprindine—CYP2D6—Vemurafenib—skin cancer	0.0701	0.0839	CbGbCtD
Aprindine—CALM2—ear—skin cancer	0.00608	0.0835	CbGeAlD
Aprindine—CALM1—ear—skin cancer	0.00605	0.0831	CbGeAlD
Aprindine—CALM2—nerve—skin cancer	0.00383	0.0525	CbGeAlD
Aprindine—CALM1—nerve—skin cancer	0.00381	0.0523	CbGeAlD
Aprindine—CALM2—endothelium—skin cancer	0.00326	0.0447	CbGeAlD
Aprindine—CALM1—endothelium—skin cancer	0.00324	0.0445	CbGeAlD
Aprindine—CALM2—hair follicle—skin cancer	0.00321	0.044	CbGeAlD
Aprindine—CALM2—blood vessel—skin cancer	0.00301	0.0413	CbGeAlD
Aprindine—CALM1—blood vessel—skin cancer	0.00299	0.0411	CbGeAlD
Aprindine—CALM3—nipple—skin cancer	0.00277	0.038	CbGeAlD
Aprindine—CALM2—nipple—skin cancer	0.00217	0.0298	CbGeAlD
Aprindine—CALM1—nipple—skin cancer	0.00216	0.0297	CbGeAlD
Aprindine—CALM2—neck—skin cancer	0.00215	0.0295	CbGeAlD
Aprindine—CALM1—neck—skin cancer	0.00214	0.0294	CbGeAlD
Aprindine—CALM3—mammalian vulva—skin cancer	0.00162	0.0222	CbGeAlD
Aprindine—CALM2—connective tissue—skin cancer	0.00154	0.0212	CbGeAlD
Aprindine—CALM1—connective tissue—skin cancer	0.00153	0.0211	CbGeAlD
Aprindine—CALM2—epithelium—skin cancer	0.00146	0.0201	CbGeAlD
Aprindine—ORM1—female reproductive system—skin cancer	0.00146	0.0201	CbGeAlD
Aprindine—CALM1—epithelium—skin cancer	0.00146	0.02	CbGeAlD
Aprindine—CALM2—skin of body—skin cancer	0.00139	0.0191	CbGeAlD
Aprindine—CALM1—skin of body—skin cancer	0.00139	0.019	CbGeAlD
Aprindine—SCN5A—head—skin cancer	0.00134	0.0184	CbGeAlD
Aprindine—CALM2—mammalian vulva—skin cancer	0.00127	0.0174	CbGeAlD
Aprindine—CALM1—mammalian vulva—skin cancer	0.00126	0.0173	CbGeAlD
Aprindine—CALM2—lymphoid tissue—skin cancer	0.00113	0.0155	CbGeAlD
Aprindine—CALM1—lymphoid tissue—skin cancer	0.00112	0.0154	CbGeAlD
Aprindine—CALM2—female reproductive system—skin cancer	0.00109	0.0149	CbGeAlD
Aprindine—CALM1—female reproductive system—skin cancer	0.00108	0.0148	CbGeAlD
Aprindine—CALM2—head—skin cancer	0.000908	0.0125	CbGeAlD
Aprindine—CALM1—head—skin cancer	0.000904	0.0124	CbGeAlD
Aprindine—ORM1—lymph node—skin cancer	0.000855	0.0117	CbGeAlD
Aprindine—CALM3—lymph node—skin cancer	0.00081	0.0111	CbGeAlD
Aprindine—CALM2—lymph node—skin cancer	0.000636	0.00873	CbGeAlD
Aprindine—CALM1—lymph node—skin cancer	0.000633	0.00869	CbGeAlD
Aprindine—CYP2D6—female reproductive system—skin cancer	0.0006	0.00824	CbGeAlD
Aprindine—CYP2D6—head—skin cancer	0.000502	0.00688	CbGeAlD
Aprindine—CALM1—Downstream signaling of activated FGFR—IL6—skin cancer	5.17e-05	0.000568	CbGpPWpGaD
Aprindine—CALM2—Downstream signaling of activated FGFR—IL6—skin cancer	5.17e-05	0.000568	CbGpPWpGaD
Aprindine—CALM3—Disease—SHH—skin cancer	5.13e-05	0.000564	CbGpPWpGaD
Aprindine—CALM3—Disease—ENO2—skin cancer	5.13e-05	0.000564	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—KRAS—skin cancer	5.13e-05	0.000563	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—KRAS—skin cancer	5.13e-05	0.000563	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—GLI2—skin cancer	5.11e-05	0.000562	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—GLI2—skin cancer	5.11e-05	0.000562	CbGpPWpGaD
Aprindine—CALM2—Downstream signal transduction—HRAS—skin cancer	5.08e-05	0.000558	CbGpPWpGaD
Aprindine—CALM1—Downstream signal transduction—HRAS—skin cancer	5.08e-05	0.000558	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	5.07e-05	0.000557	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR—HRAS—skin cancer	5.05e-05	0.000555	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR—HRAS—skin cancer	5.05e-05	0.000555	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—MC1R—skin cancer	5.04e-05	0.000554	CbGpPWpGaD
Aprindine—CALM2—Signaling by ERBB2—HRAS—skin cancer	5.03e-05	0.000553	CbGpPWpGaD
Aprindine—CALM1—Signaling by ERBB2—HRAS—skin cancer	5.03e-05	0.000553	CbGpPWpGaD
Aprindine—CALM3—Downstream signal transduction—IL6—skin cancer	5.03e-05	0.000552	CbGpPWpGaD
Aprindine—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	5.01e-05	0.000551	CbGpPWpGaD
Aprindine—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	5.01e-05	0.000551	CbGpPWpGaD
Aprindine—CALM2—DAP12 signaling—HRAS—skin cancer	5e-05	0.00055	CbGpPWpGaD
Aprindine—CALM1—DAP12 signaling—HRAS—skin cancer	5e-05	0.00055	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR—IL6—skin cancer	5e-05	0.000549	CbGpPWpGaD
Aprindine—CALM3—Signaling by ERBB2—IL6—skin cancer	4.98e-05	0.000547	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—GLI1—skin cancer	4.97e-05	0.000546	CbGpPWpGaD
Aprindine—CALM1—Disease—SHH—skin cancer	4.96e-05	0.000545	CbGpPWpGaD
Aprindine—CALM2—Disease—SHH—skin cancer	4.96e-05	0.000545	CbGpPWpGaD
Aprindine—CALM2—Disease—ENO2—skin cancer	4.96e-05	0.000545	CbGpPWpGaD
Aprindine—CALM1—Disease—ENO2—skin cancer	4.96e-05	0.000545	CbGpPWpGaD
Aprindine—CALM3—DAP12 signaling—IL6—skin cancer	4.95e-05	0.000544	CbGpPWpGaD
Aprindine—SCN5A—Developmental Biology—HRAS—skin cancer	4.91e-05	0.000539	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	4.91e-05	0.000539	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	4.91e-05	0.000539	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—MC1R—skin cancer	4.88e-05	0.000536	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—MC1R—skin cancer	4.88e-05	0.000536	CbGpPWpGaD
Aprindine—CALM3—DAP12 interactions—HRAS—skin cancer	4.87e-05	0.000535	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR in disease—HRAS—skin cancer	4.87e-05	0.000535	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	4.87e-05	0.000535	CbGpPWpGaD
Aprindine—CALM2—Downstream signal transduction—IL6—skin cancer	4.86e-05	0.000534	CbGpPWpGaD
Aprindine—CALM1—Downstream signal transduction—IL6—skin cancer	4.86e-05	0.000534	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR—IL6—skin cancer	4.84e-05	0.000531	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR—IL6—skin cancer	4.84e-05	0.000531	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR—HRAS—skin cancer	4.82e-05	0.00053	CbGpPWpGaD
Aprindine—CALM2—Signaling by ERBB2—IL6—skin cancer	4.81e-05	0.000529	CbGpPWpGaD
Aprindine—CALM1—Signaling by ERBB2—IL6—skin cancer	4.81e-05	0.000529	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—GLI1—skin cancer	4.81e-05	0.000528	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—GLI1—skin cancer	4.81e-05	0.000528	CbGpPWpGaD
Aprindine—CALM2—DAP12 signaling—IL6—skin cancer	4.79e-05	0.000526	CbGpPWpGaD
Aprindine—CALM1—DAP12 signaling—IL6—skin cancer	4.79e-05	0.000526	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR in Cancer—HRAS—skin cancer	4.78e-05	0.000525	CbGpPWpGaD
Aprindine—CALM3—Signaling by PDGF—HRAS—skin cancer	4.76e-05	0.000523	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—SUFU—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM1—DAP12 interactions—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM2—DAP12 interactions—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR in disease—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR in disease—HRAS—skin cancer	4.71e-05	0.000517	CbGpPWpGaD
Aprindine—SCN5A—Developmental Biology—IL6—skin cancer	4.7e-05	0.000516	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR—HRAS—skin cancer	4.67e-05	0.000513	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR—HRAS—skin cancer	4.67e-05	0.000513	CbGpPWpGaD
Aprindine—CALM3—Signaling by FGFR in disease—IL6—skin cancer	4.66e-05	0.000512	CbGpPWpGaD
Aprindine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	4.66e-05	0.000512	CbGpPWpGaD
Aprindine—CALM3—DAP12 interactions—IL6—skin cancer	4.66e-05	0.000512	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR in Cancer—HRAS—skin cancer	4.62e-05	0.000508	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR in Cancer—HRAS—skin cancer	4.62e-05	0.000508	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR—IL6—skin cancer	4.62e-05	0.000507	CbGpPWpGaD
Aprindine—CALM1—Signaling by PDGF—HRAS—skin cancer	4.6e-05	0.000506	CbGpPWpGaD
Aprindine—CALM2—Signaling by PDGF—HRAS—skin cancer	4.6e-05	0.000506	CbGpPWpGaD
Aprindine—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	4.58e-05	0.000503	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—SUFU—skin cancer	4.56e-05	0.000501	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—SUFU—skin cancer	4.56e-05	0.000501	CbGpPWpGaD
Aprindine—CALM3—Signaling by PDGF—IL6—skin cancer	4.56e-05	0.000501	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—NRAS—skin cancer	4.53e-05	0.000498	CbGpPWpGaD
Aprindine—CALM3—Immune System—FOXO4—skin cancer	4.53e-05	0.000498	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—CSPG4—skin cancer	4.51e-05	0.000496	CbGpPWpGaD
Aprindine—CALM1—DAP12 interactions—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM2—Signaling by FGFR in disease—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM1—Signaling by FGFR in disease—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM2—DAP12 interactions—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	4.51e-05	0.000495	CbGpPWpGaD
Aprindine—CALM3—B Cell Activation—HRAS—skin cancer	4.5e-05	0.000495	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR—IL6—skin cancer	4.47e-05	0.000491	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR—IL6—skin cancer	4.47e-05	0.000491	CbGpPWpGaD
Aprindine—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	4.43e-05	0.000486	CbGpPWpGaD
Aprindine—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	4.43e-05	0.000486	CbGpPWpGaD
Aprindine—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	4.41e-05	0.000485	CbGpPWpGaD
Aprindine—CALM2—Signaling by PDGF—IL6—skin cancer	4.41e-05	0.000484	CbGpPWpGaD
Aprindine—CALM1—Signaling by PDGF—IL6—skin cancer	4.41e-05	0.000484	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—NRAS—skin cancer	4.38e-05	0.000482	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—NRAS—skin cancer	4.38e-05	0.000482	CbGpPWpGaD
Aprindine—CALM2—Immune System—FOXO4—skin cancer	4.38e-05	0.000481	CbGpPWpGaD
Aprindine—CALM1—Immune System—FOXO4—skin cancer	4.38e-05	0.000481	CbGpPWpGaD
Aprindine—CALM2—B Cell Activation—HRAS—skin cancer	4.36e-05	0.000479	CbGpPWpGaD
Aprindine—CALM1—B Cell Activation—HRAS—skin cancer	4.36e-05	0.000479	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	4.31e-05	0.000474	CbGpPWpGaD
Aprindine—CALM3—Metabolism—ENO2—skin cancer	4.3e-05	0.000472	CbGpPWpGaD
Aprindine—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	4.27e-05	0.000469	CbGpPWpGaD
Aprindine—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	4.27e-05	0.000469	CbGpPWpGaD
Aprindine—CALM3—Disease—FOXO4—skin cancer	4.18e-05	0.000459	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	4.17e-05	0.000458	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	4.17e-05	0.000458	CbGpPWpGaD
Aprindine—CALM2—Metabolism—ENO2—skin cancer	4.16e-05	0.000457	CbGpPWpGaD
Aprindine—CALM1—Metabolism—ENO2—skin cancer	4.16e-05	0.000457	CbGpPWpGaD
Aprindine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	4.13e-05	0.000453	CbGpPWpGaD
Aprindine—CALM1—Disease—FOXO4—skin cancer	4.04e-05	0.000444	CbGpPWpGaD
Aprindine—CALM2—Disease—FOXO4—skin cancer	4.04e-05	0.000444	CbGpPWpGaD
Aprindine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	3.99e-05	0.000438	CbGpPWpGaD
Aprindine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	3.99e-05	0.000438	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—KRAS—skin cancer	3.9e-05	0.000429	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—KRAS—skin cancer	3.77e-05	0.000415	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—KRAS—skin cancer	3.77e-05	0.000415	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—SHH—skin cancer	3.59e-05	0.000395	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—RASA1—skin cancer	3.57e-05	0.000392	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—SHH—skin cancer	3.47e-05	0.000382	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—SHH—skin cancer	3.47e-05	0.000382	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—RASA1—skin cancer	3.45e-05	0.000379	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—RASA1—skin cancer	3.45e-05	0.000379	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—SMO—skin cancer	3.41e-05	0.000374	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—PTCH1—skin cancer	3.41e-05	0.000374	CbGpPWpGaD
Aprindine—CALM3—Neuronal System—HRAS—skin cancer	3.38e-05	0.000372	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—HRAS—skin cancer	3.32e-05	0.000364	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—PTGER4—skin cancer	3.31e-05	0.000364	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—SMO—skin cancer	3.29e-05	0.000362	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—SMO—skin cancer	3.29e-05	0.000362	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—PTCH1—skin cancer	3.29e-05	0.000362	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—PTCH1—skin cancer	3.29e-05	0.000362	CbGpPWpGaD
Aprindine—CALM1—Neuronal System—HRAS—skin cancer	3.27e-05	0.000359	CbGpPWpGaD
Aprindine—CALM2—Neuronal System—HRAS—skin cancer	3.27e-05	0.000359	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—HRAS—skin cancer	3.21e-05	0.000352	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—HRAS—skin cancer	3.21e-05	0.000352	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—PTGER4—skin cancer	3.21e-05	0.000352	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—PTGER4—skin cancer	3.21e-05	0.000352	CbGpPWpGaD
Aprindine—CALM3—Signaling by NGF—IL6—skin cancer	3.17e-05	0.000349	CbGpPWpGaD
Aprindine—CALM1—Signaling by NGF—IL6—skin cancer	3.07e-05	0.000337	CbGpPWpGaD
Aprindine—CALM2—Signaling by NGF—IL6—skin cancer	3.07e-05	0.000337	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—ENO2—skin cancer	3.07e-05	0.000337	CbGpPWpGaD
Aprindine—CALM3—Disease—ERCC2—skin cancer	2.98e-05	0.000327	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—FOXO4—skin cancer	2.93e-05	0.000322	CbGpPWpGaD
Aprindine—CALM2—Disease—ERCC2—skin cancer	2.88e-05	0.000317	CbGpPWpGaD
Aprindine—CALM1—Disease—ERCC2—skin cancer	2.88e-05	0.000317	CbGpPWpGaD
Aprindine—CALM3—Hemostasis—NRAS—skin cancer	2.87e-05	0.000315	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—FOXO4—skin cancer	2.83e-05	0.000311	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—FOXO4—skin cancer	2.83e-05	0.000311	CbGpPWpGaD
Aprindine—CALM3—Disease—TERT—skin cancer	2.79e-05	0.000307	CbGpPWpGaD
Aprindine—CALM2—Hemostasis—NRAS—skin cancer	2.78e-05	0.000305	CbGpPWpGaD
Aprindine—CALM1—Hemostasis—NRAS—skin cancer	2.78e-05	0.000305	CbGpPWpGaD
Aprindine—CALM1—Disease—TERT—skin cancer	2.7e-05	0.000297	CbGpPWpGaD
Aprindine—CALM2—Disease—TERT—skin cancer	2.7e-05	0.000297	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—NRAS—skin cancer	2.58e-05	0.000284	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—NRAS—skin cancer	2.5e-05	0.000275	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—NRAS—skin cancer	2.5e-05	0.000275	CbGpPWpGaD
Aprindine—CALM3—Metabolism—ERCC2—skin cancer	2.5e-05	0.000274	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—NRAS—skin cancer	2.48e-05	0.000273	CbGpPWpGaD
Aprindine—CALM3—Hemostasis—KRAS—skin cancer	2.47e-05	0.000271	CbGpPWpGaD
Aprindine—CALM2—Metabolism—ERCC2—skin cancer	2.41e-05	0.000265	CbGpPWpGaD
Aprindine—CALM1—Metabolism—ERCC2—skin cancer	2.41e-05	0.000265	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—NRAS—skin cancer	2.4e-05	0.000264	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—NRAS—skin cancer	2.4e-05	0.000264	CbGpPWpGaD
Aprindine—CALM2—Hemostasis—KRAS—skin cancer	2.39e-05	0.000263	CbGpPWpGaD
Aprindine—CALM1—Hemostasis—KRAS—skin cancer	2.39e-05	0.000263	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—KRAS—skin cancer	2.22e-05	0.000244	CbGpPWpGaD
Aprindine—CALM3—Disease—BRAF—skin cancer	2.21e-05	0.000243	CbGpPWpGaD
Aprindine—CALM3—Hemostasis—TP53—skin cancer	2.2e-05	0.000241	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—KRAS—skin cancer	2.15e-05	0.000236	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—KRAS—skin cancer	2.15e-05	0.000236	CbGpPWpGaD
Aprindine—CALM1—Disease—BRAF—skin cancer	2.14e-05	0.000235	CbGpPWpGaD
Aprindine—CALM2—Disease—BRAF—skin cancer	2.14e-05	0.000235	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—KRAS—skin cancer	2.14e-05	0.000235	CbGpPWpGaD
Aprindine—CALM2—Hemostasis—TP53—skin cancer	2.12e-05	0.000233	CbGpPWpGaD
Aprindine—CALM1—Hemostasis—TP53—skin cancer	2.12e-05	0.000233	CbGpPWpGaD
Aprindine—CALM3—Hemostasis—HRAS—skin cancer	2.1e-05	0.000231	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—KRAS—skin cancer	2.07e-05	0.000227	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—KRAS—skin cancer	2.07e-05	0.000227	CbGpPWpGaD
Aprindine—CALM2—Hemostasis—HRAS—skin cancer	2.03e-05	0.000223	CbGpPWpGaD
Aprindine—CALM1—Hemostasis—HRAS—skin cancer	2.03e-05	0.000223	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—TERT—skin cancer	1.96e-05	0.000215	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—TERT—skin cancer	1.89e-05	0.000208	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—TERT—skin cancer	1.89e-05	0.000208	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—HRAS—skin cancer	1.89e-05	0.000208	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—HRAS—skin cancer	1.83e-05	0.000201	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—HRAS—skin cancer	1.83e-05	0.000201	CbGpPWpGaD
Aprindine—CALM3—Adaptive Immune System—HRAS—skin cancer	1.82e-05	0.0002	CbGpPWpGaD
Aprindine—CALM3—Innate Immune System—IL6—skin cancer	1.81e-05	0.000199	CbGpPWpGaD
Aprindine—CALM3—Disease—PTGS2—skin cancer	1.79e-05	0.000196	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—ERCC2—skin cancer	1.78e-05	0.000196	CbGpPWpGaD
Aprindine—CALM1—Adaptive Immune System—HRAS—skin cancer	1.76e-05	0.000193	CbGpPWpGaD
Aprindine—CALM2—Adaptive Immune System—HRAS—skin cancer	1.76e-05	0.000193	CbGpPWpGaD
Aprindine—CALM2—Innate Immune System—IL6—skin cancer	1.75e-05	0.000192	CbGpPWpGaD
Aprindine—CALM1—Innate Immune System—IL6—skin cancer	1.75e-05	0.000192	CbGpPWpGaD
Aprindine—CALM1—Disease—PTGS2—skin cancer	1.73e-05	0.00019	CbGpPWpGaD
Aprindine—CALM2—Disease—PTGS2—skin cancer	1.73e-05	0.00019	CbGpPWpGaD
Aprindine—CALM3—Signaling by GPCR—NRAS—skin cancer	1.65e-05	0.000181	CbGpPWpGaD
Aprindine—CALM2—Signaling by GPCR—NRAS—skin cancer	1.59e-05	0.000175	CbGpPWpGaD
Aprindine—CALM1—Signaling by GPCR—NRAS—skin cancer	1.59e-05	0.000175	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—BRAF—skin cancer	1.55e-05	0.00017	CbGpPWpGaD
Aprindine—CALM3—Immune System—NRAS—skin cancer	1.51e-05	0.000165	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—BRAF—skin cancer	1.5e-05	0.000165	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—BRAF—skin cancer	1.5e-05	0.000165	CbGpPWpGaD
Aprindine—CALM3—Metabolism—PTGS2—skin cancer	1.5e-05	0.000164	CbGpPWpGaD
Aprindine—CALM2—Immune System—NRAS—skin cancer	1.46e-05	0.00016	CbGpPWpGaD
Aprindine—CALM1—Immune System—NRAS—skin cancer	1.46e-05	0.00016	CbGpPWpGaD
Aprindine—CALM1—Metabolism—PTGS2—skin cancer	1.45e-05	0.000159	CbGpPWpGaD
Aprindine—CALM2—Metabolism—PTGS2—skin cancer	1.45e-05	0.000159	CbGpPWpGaD
Aprindine—CALM3—Signaling by GPCR—KRAS—skin cancer	1.42e-05	0.000156	CbGpPWpGaD
Aprindine—CALM3—Disease—NRAS—skin cancer	1.39e-05	0.000153	CbGpPWpGaD
Aprindine—CALM1—Signaling by GPCR—KRAS—skin cancer	1.37e-05	0.000151	CbGpPWpGaD
Aprindine—CALM2—Signaling by GPCR—KRAS—skin cancer	1.37e-05	0.000151	CbGpPWpGaD
Aprindine—CALM2—Disease—NRAS—skin cancer	1.34e-05	0.000148	CbGpPWpGaD
Aprindine—CALM1—Disease—NRAS—skin cancer	1.34e-05	0.000148	CbGpPWpGaD
Aprindine—CALM3—Immune System—KRAS—skin cancer	1.3e-05	0.000142	CbGpPWpGaD
Aprindine—CALM2—Immune System—KRAS—skin cancer	1.25e-05	0.000138	CbGpPWpGaD
Aprindine—CALM1—Immune System—KRAS—skin cancer	1.25e-05	0.000138	CbGpPWpGaD
Aprindine—CALM3—Signaling by GPCR—HRAS—skin cancer	1.21e-05	0.000132	CbGpPWpGaD
Aprindine—CALM3—Disease—KRAS—skin cancer	1.2e-05	0.000131	CbGpPWpGaD
Aprindine—CALM1—Signaling by GPCR—HRAS—skin cancer	1.17e-05	0.000128	CbGpPWpGaD
Aprindine—CALM2—Signaling by GPCR—HRAS—skin cancer	1.17e-05	0.000128	CbGpPWpGaD
Aprindine—CALM2—Disease—KRAS—skin cancer	1.16e-05	0.000127	CbGpPWpGaD
Aprindine—CALM1—Disease—KRAS—skin cancer	1.16e-05	0.000127	CbGpPWpGaD
Aprindine—CALM3—Signaling by GPCR—IL6—skin cancer	1.15e-05	0.000127	CbGpPWpGaD
Aprindine—CALM2—Signaling by GPCR—IL6—skin cancer	1.12e-05	0.000123	CbGpPWpGaD
Aprindine—CALM1—Signaling by GPCR—IL6—skin cancer	1.12e-05	0.000123	CbGpPWpGaD
Aprindine—CALM3—Immune System—HRAS—skin cancer	1.1e-05	0.000121	CbGpPWpGaD
Aprindine—CYP2D6—Metabolism—PTGS2—skin cancer	1.07e-05	0.000117	CbGpPWpGaD
Aprindine—CALM2—Immune System—HRAS—skin cancer	1.07e-05	0.000117	CbGpPWpGaD
Aprindine—CALM1—Immune System—HRAS—skin cancer	1.07e-05	0.000117	CbGpPWpGaD
Aprindine—CALM3—Immune System—IL6—skin cancer	1.05e-05	0.000116	CbGpPWpGaD
Aprindine—CALM1—Immune System—IL6—skin cancer	1.02e-05	0.000112	CbGpPWpGaD
Aprindine—CALM2—Immune System—IL6—skin cancer	1.02e-05	0.000112	CbGpPWpGaD
Aprindine—CALM3—Disease—HRAS—skin cancer	1.02e-05	0.000112	CbGpPWpGaD
Aprindine—CALM2—Disease—HRAS—skin cancer	9.84e-06	0.000108	CbGpPWpGaD
Aprindine—CALM1—Disease—HRAS—skin cancer	9.84e-06	0.000108	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—NRAS—skin cancer	9.73e-06	0.000107	CbGpPWpGaD
Aprindine—CALM3—Disease—IL6—skin cancer	9.73e-06	0.000107	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—NRAS—skin cancer	9.42e-06	0.000103	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—NRAS—skin cancer	9.42e-06	0.000103	CbGpPWpGaD
Aprindine—CALM1—Disease—IL6—skin cancer	9.42e-06	0.000103	CbGpPWpGaD
Aprindine—CALM2—Disease—IL6—skin cancer	9.42e-06	0.000103	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—KRAS—skin cancer	8.38e-06	9.2e-05	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—KRAS—skin cancer	8.1e-06	8.9e-05	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—KRAS—skin cancer	8.1e-06	8.9e-05	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—TP53—skin cancer	7.45e-06	8.18e-05	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—TP53—skin cancer	7.2e-06	7.91e-05	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—TP53—skin cancer	7.2e-06	7.91e-05	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—HRAS—skin cancer	7.12e-06	7.82e-05	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—HRAS—skin cancer	6.89e-06	7.57e-05	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—HRAS—skin cancer	6.89e-06	7.57e-05	CbGpPWpGaD
Aprindine—CALM3—Signaling Pathways—IL6—skin cancer	6.82e-06	7.49e-05	CbGpPWpGaD
Aprindine—CALM2—Signaling Pathways—IL6—skin cancer	6.59e-06	7.24e-05	CbGpPWpGaD
Aprindine—CALM1—Signaling Pathways—IL6—skin cancer	6.59e-06	7.24e-05	CbGpPWpGaD
